UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
CELLSTAR CORPORATION
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $.01 per share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
150925 6
- --------------------------------------------------------------------------------
(CUSIP Number)
Robert J. Mittman, Esq.
Tenzer Greenblatt LLP
405 Lexington Avenue, New York, New York 10174
(212) 885-5000
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
January 31, 1997
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing
of this Statement)
If the filing person has previously filed a statement of Schedule 13G to report
the acquisition which is the subject of the Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-1(a) for other parties to whom copies are to be
sent.
*The remainder of this cover page shall be filed out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 4 Pages
<PAGE>
SCHEDULE 13D
CUSIP No. 150925 6 Page 2 of 4 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Brightpoint, Inc.
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [ ]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 400,000
BENEFICIALLY --------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH -0-
REPORTING --------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH 400,000
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
-0-
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
400,000
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[ ]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
2.1%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEM 1-7 (INCLUDING EXHIBITS)
OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
Page 2 of 4 Pages
<PAGE>
This Amendment No. 1 amends the Schedule 13D dated December 18, 1996 of
Brightpoint, Inc. ("Brightpoint") with respect to the common stock, par value
$.01 per share ("Common Stock"), issued by Cellstar Corporation (the
"Corporation"). Except as modified hereby, there has been no change in the
information previously reported in the Schedule 13D dated December 18, 1996 of
Brightpoint.
On January 31, 1997, Brightpoint, as more fully described under Paragraph
(c) of Item 5 herein, ceased to be a beneficial owner of more than five percent
of the Common Stock of the Corporation upon consummation of the sale, in
over-the-counter market transactions, of a number of shares of Common Stock of
the Corporation.
Item 5. Interest in Securities of the Issuer.
(a) As of January 31, 1997, Brightpoint beneficially owned 400,000 shares
of Common Stock, constituting, to the best of the knowledge of Brightpoint, 2.1%
of the issued and outstanding shares of Common Stock based on the outstanding
number of shares of Common Stock as reported in the Corporation's Quarterly
Report on Form 10-Q for the quarter ending August 31, 1996.
(b) Brightpoint has sole power to vote or to direct the vote of, and sole
power to dispose or to direct the disposition of, 400,000 shares of Common
Stock.
(c) Since December 18, 1996, Brightpoint has disposed of 600,000 shares of
Common Stock in over-the-counter market transactions on the NASDAQ National
Market System, as follows:
Sale Price
Date Shares Per Share
---- ------ ---------
1/31/97 500,000 $22.75
1/31/97 100,000 $23.125
(d) Not applicable.
(e) As of January 31, 1997, Brightpoint ceased to be the beneficial owner
of more than five percent of the Common Stock of the Corporation.
Page 3 of 4 Pages
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of its knowledge and belief,
Brightpoint certifies that the information set forth in this statement is true,
complete and correct.
Dated: February 4, 1997 BRIGHTPOINT, INC.
By: /s/ Robert J. Laikin
---------------------
Name: Robert J. Laikin
Title: Chairman of the Board
and Chief Executive Officer
Page 4 of 4 Pages
